Company Profile
Overview
Choose Your Horizon is an innovative company dedicated to advancing mental health care through at-home psychedelic therapy, primarily focusing on ketamine and naltrexone treatments. Established in 2021 and headquartered in Austin, Texas, the company delivers personalized psychiatric care across the United States. Its mission is to provide patient-first medical care to those dealing with mental health disorders such as depression, anxiety, PTSD, and addiction. Operated as a privately held entity, Choose Your Horizon employs a team of 11 to 50 professionals driven by a shared vision of mental health transformation.
Services Offered
Choose Your Horizon is distinguished by its innovative, at-home ketamine-assisted therapy, which is designed to offer quicker relief in comparison to conventional methods. These guided sessions are conducted through telemedicine, ensuring a secure and supportive environment for clients. The company also provides naltrexone therapy, focusing on transforming alcohol relationships towards sobriety and moderation within a private setting. These services are currently available in selected states, including Georgia, Texas, and California.
Treatment Efficacy and Reach
To date, Choose Your Horizon has successfully facilitated over 12,000 guided oral ketamine sessions across 23 states, with a remarkable 98% of patients reporting improvements within four weeks. The occurrence of adverse side effects remains minimal, affecting less than 1% of patients. By capitalizing on its telehealth platform, the company has remarkably expanded access to advanced therapies, driving significant improvements in patients' mental health and wellbeing.
Leadership
The leadership at Choose Your Horizon is spearheaded by Dr. Daniel Montville, Chief Medical Officer, alongside well-respected experts like Dr. Stephanie Lyn Coleman and Dominique Louis. Their combined expertise in psychedelic medicine, addiction recovery, and behavioral health fortifies the company's mission of redefining mental health treatment.
Financial Initiatives and Growth
To fuel its growth, Choose Your Horizon engages actively in financial initiatives such as equity crowdfunding. The company has conducted campaigns to secure capital for its nationwide expansion strategy, securing over $580,000 soon after launching its StartEngine campaign. With a valuation standing at $22.1 million, the company's financial maneuvers demonstrate substantial investor confidence and promising future growth potential.
Industry Recognition and Community Engagement
Highlighting its impact and industry leadership, the company received a nomination for Founder of the Year at the North American Startup Awards, affiliated with the Global Startup Awards. This recognition underscores its commitment to revolutionizing mental health care through innovative solutions.
Competitor Profile
Competitors Overview
The competitive landscape for Choose Your Horizon comprises other leaders in the field of psychedelic therapy:
- Mindbloom: Known for offering home-based injectable therapies, it represents a significant competitor in guided ketamine therapy. Choose Your Horizon offers sessions at a competitive rate of $87 per experience for 12 sessions while Mindbloom's packages start at $209 per session for a package of six.
- Journey Clinical: Facilitates the connection between licensed professionals and patients for psychedelic-assisted psychotherapy, emphasizing a broad network of therapists.
- Nue Life Health: Offers technology-integrated psychedelic wellness treatments with a focus on evidence-based therapy and clinical outcomes.
- Field Trip Health: Provides both in-person and digital psychedelic interventions, including ketamine-assisted therapy, with a presence in multiple U.S. locations.
Market Position and Differentiation
Choose Your Horizon’s market position benefits from its emphasis on cost-effective, at-home therapies and covering conditions beyond the conventional purview, such as OCD and PTSD. This positions the company apart from clinic-centered competitors like Field Trip Health. Its holistic and accessible approach is supported by competitive pricing strategies compared to market players like Mindbloom.
Industry Trends
The psychedelic therapy landscape continues to grow, with ketamine emerging as a popular solution for treatment-resistant mental health conditions. The industry trend reflects a movement towards patient convenience and digitally integrated care, as demonstrated by companies such as Mindbloom and Nue Life, who are enhancing patient experience and engagement through technological platforms.
